Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice

Abstract Background It is becoming increasingly recognized that weight and nutritional status can impact cancer survival. We have previously shown that obese mice with syngeneic acute lymphoblastic leukemia (ALL) have poorer response to chemotherapy treatment than control mice. We therefore investig...

Full description

Bibliographic Details
Main Authors: Jonathan Tucci, Waseem Alhushki, Ting Chen, Xia Sheng, Yong-Mi Kim, Steven D. Mittelman
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Cancer & Metabolism
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40170-018-0189-0
_version_ 1818448735962660864
author Jonathan Tucci
Waseem Alhushki
Ting Chen
Xia Sheng
Yong-Mi Kim
Steven D. Mittelman
author_facet Jonathan Tucci
Waseem Alhushki
Ting Chen
Xia Sheng
Yong-Mi Kim
Steven D. Mittelman
author_sort Jonathan Tucci
collection DOAJ
description Abstract Background It is becoming increasingly recognized that weight and nutritional status can impact cancer survival. We have previously shown that obese mice with syngeneic acute lymphoblastic leukemia (ALL) have poorer response to chemotherapy treatment than control mice. We therefore investigated whether dietary intervention could improve outcome from the most common pediatric cancer, ALL. Methods Diet-induced obese (DIO) mice raised on a 60% calories from fat diet and control mice were implanted with syngeneic ALL cells. Some DIO mice were switched to the low-fat control diet. Survival from ALL was assessed without or with chemotherapy treatment starting at the time of the diet switch. Cells from DIO mice before and after diet switch were assessed by FACS for BrdU incorporation and phosphorylation status of AKT, S6K, and EIF2a. Similar experiments were done with human ALL xenografts. Mouse and human ALL cells were cultured in media with 10% or 5% fetal bovine serum, and sensitivity to chemotherapies assessed. Results DIO mice had poorer survival (17%) after vincristine monotherapy than control mice on a 10% low fat diet (42%; n = 12/group; p = 0.09, log rank). However, switching obese mice to the low-fat diet prior to initiation of vincristine led to dramatically improved survival (92%, p < 0.01 vs both other groups). In vitro, FBS restriction made murine and human ALL cells more sensitive to vincristine. Interestingly, while serum restriction enhanced ALL sensitivity to dexamethasone and l-asparaginase, dietary switch did not improve survival of DIO mice treated with either drug in monotherapy. Thus, it appears that dietary intervention has a unique effect to improve ALL cell sensitivity to vincristine in vivo. Conclusions We report herein that a dietary intervention can improve ALL outcome in a preclinical model. Further work is needed to identify the mechanisms of this effect and investigate potential impact on human leukemia in patients.
first_indexed 2024-12-14T20:24:15Z
format Article
id doaj.art-e26c2432f7604924b6e1d9475d9cfe5f
institution Directory Open Access Journal
issn 2049-3002
language English
last_indexed 2024-12-14T20:24:15Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Cancer & Metabolism
spelling doaj.art-e26c2432f7604924b6e1d9475d9cfe5f2022-12-21T22:48:39ZengBMCCancer & Metabolism2049-30022018-11-01611810.1186/s40170-018-0189-0Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese miceJonathan Tucci0Waseem Alhushki1Ting Chen2Xia Sheng3Yong-Mi Kim4Steven D. Mittelman5Diabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern CaliforniaChildren’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern CaliforniaDivision of Pediatric Endocrinology, UCLA Children’s Discovery and Innovation Institute, David Geffen School of Medicine UCLADiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern CaliforniaChildren’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern CaliforniaDiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern CaliforniaAbstract Background It is becoming increasingly recognized that weight and nutritional status can impact cancer survival. We have previously shown that obese mice with syngeneic acute lymphoblastic leukemia (ALL) have poorer response to chemotherapy treatment than control mice. We therefore investigated whether dietary intervention could improve outcome from the most common pediatric cancer, ALL. Methods Diet-induced obese (DIO) mice raised on a 60% calories from fat diet and control mice were implanted with syngeneic ALL cells. Some DIO mice were switched to the low-fat control diet. Survival from ALL was assessed without or with chemotherapy treatment starting at the time of the diet switch. Cells from DIO mice before and after diet switch were assessed by FACS for BrdU incorporation and phosphorylation status of AKT, S6K, and EIF2a. Similar experiments were done with human ALL xenografts. Mouse and human ALL cells were cultured in media with 10% or 5% fetal bovine serum, and sensitivity to chemotherapies assessed. Results DIO mice had poorer survival (17%) after vincristine monotherapy than control mice on a 10% low fat diet (42%; n = 12/group; p = 0.09, log rank). However, switching obese mice to the low-fat diet prior to initiation of vincristine led to dramatically improved survival (92%, p < 0.01 vs both other groups). In vitro, FBS restriction made murine and human ALL cells more sensitive to vincristine. Interestingly, while serum restriction enhanced ALL sensitivity to dexamethasone and l-asparaginase, dietary switch did not improve survival of DIO mice treated with either drug in monotherapy. Thus, it appears that dietary intervention has a unique effect to improve ALL cell sensitivity to vincristine in vivo. Conclusions We report herein that a dietary intervention can improve ALL outcome in a preclinical model. Further work is needed to identify the mechanisms of this effect and investigate potential impact on human leukemia in patients.http://link.springer.com/article/10.1186/s40170-018-0189-0ObesityAdipose tissueDietary interventionChemotherapyCaloric restriction
spellingShingle Jonathan Tucci
Waseem Alhushki
Ting Chen
Xia Sheng
Yong-Mi Kim
Steven D. Mittelman
Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
Cancer & Metabolism
Obesity
Adipose tissue
Dietary intervention
Chemotherapy
Caloric restriction
title Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
title_full Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
title_fullStr Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
title_full_unstemmed Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
title_short Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
title_sort switch to low fat diet improves outcome of acute lymphoblastic leukemia in obese mice
topic Obesity
Adipose tissue
Dietary intervention
Chemotherapy
Caloric restriction
url http://link.springer.com/article/10.1186/s40170-018-0189-0
work_keys_str_mv AT jonathantucci switchtolowfatdietimprovesoutcomeofacutelymphoblasticleukemiainobesemice
AT waseemalhushki switchtolowfatdietimprovesoutcomeofacutelymphoblasticleukemiainobesemice
AT tingchen switchtolowfatdietimprovesoutcomeofacutelymphoblasticleukemiainobesemice
AT xiasheng switchtolowfatdietimprovesoutcomeofacutelymphoblasticleukemiainobesemice
AT yongmikim switchtolowfatdietimprovesoutcomeofacutelymphoblasticleukemiainobesemice
AT stevendmittelman switchtolowfatdietimprovesoutcomeofacutelymphoblasticleukemiainobesemice